@prefix jvr: <http://data.loterre.fr/ark:/67375/JVR> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix mesh: <http://id.nlm.nih.gov/mesh/vocab#> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .

jvr:-M3D60RG5-1
  skos:hiddenLabel "Nicergolin-Neuraxpharm"@en, "Circo-Maren"@en, "Sermion"@en, "FI6714"@fr, "F.I. 6714"@en, "Nicerium"@en, "Nicergolin Atid"@en, "Fisifax"@en, "Nicergolin Lindo"@en, "FI-6714"@fr, "Nicergolin Von Ct"@en, "Nicergolin-TEVA"@en, "Nicergobeta"@en, "Nicergolin-Ratiopharm"@en, "Ergobel"@en ;
  mesh:allowableQualifier jvr:-T9HQD7ST-J, jvr:-XV06LPML-W, jvr:-G4R176S9-J, jvr:-H7K65Q8S-Z, jvr:-R0ZCQ8X6-J, jvr:-W6SQV79N-S, jvr:-D0F21513-5, jvr:-BT300B3G-Q, jvr:-NHL3D2X0-S, jvr:-M63HSDM7-1, jvr:-R3QWLHRG-V, jvr:-NB0XHT3S-N, jvr:-WK5F724J-1, jvr:-G30ZJ446-J, jvr:-FWD2BGQ0-9, jvr:-S0CS1X5R-5, jvr:-HQRFT0C6-B, jvr:-Q3979798-W, jvr:-L6C0XPHT-4, jvr:-NKM836P1-M, jvr:-SBNWSM1T-R, jvr:-CB30NGKB-3, jvr:-THHNVC7V-3, jvr:-TJHVZCRZ-0, jvr:-NFTHND7Q-8 ;
  dc:created "1974-11-11"^^xsd:date ;
  skos:altLabel "Nicotergoline"@en, "Ergoline-8-methanol, 10-methoxy-1,6-dimethyl-, 5-bromo-3-pyridinecarboxylate (ester), (8beta)-"@en, "Ergoline-8-methanol, 10-methoxy-1,6-dimethyl-, 5-bromo-3-pyridinecarboxylate (ester), (8beta)-"@fr, "27848-84-6 (Nicergoline)"@fr, "27848-84-6 (Nicergoline)"@en, "JCV8365FWN"@fr, "JCV8365FWN"@en, "Nimergoline"@en ;
  skos:definition "An ergot derivative that has been used as a cerebral vasodilator and in peripheral vascular disease. It may ameliorate cognitive deficits in CEREBROVASCULAR DISORDERS."@en ;
  mesh:pharmacologicalAction jvr:-BLDG6WP6-H, jvr:-K9FBN5C5-1, jvr:-D1BX72C0-B ;
  owl:sameAs <http://id.nlm.nih.gov/mesh/D009530> ;
  a mesh:Descriptor, skos:Concept ;
  skos:broader jvr:-D6BND4D8-6 ;
  skos:inScheme jvr: ;
  skos:prefLabel "Nicergoline"@fr, "Nicergoline"@en ;
  dc:modified "2017-05-24"^^xsd:date ;
  dc:established "1991-01-01"^^xsd:date .

jvr:-BT300B3G-Q
  skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-L6C0XPHT-4
  skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-XV06LPML-W
  skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-Q3979798-W
  skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-H7K65Q8S-Z
  skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-TJHVZCRZ-0
  skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-G30ZJ446-J
  skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NFTHND7Q-8
  skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-FWD2BGQ0-9
  skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-BLDG6WP6-H
  skos:prefLabel "Adrenergic alpha-Antagonists"@en, "Antagonistes alpha-adrénergiques"@fr ;
  a mesh:Descriptor, skos:Concept .

jvr:-THHNVC7V-3
  skos:prefLabel "synthèse chimique (Qualificatif)"@fr, "chemical synthesis (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-D6BND4D8-6
  skos:prefLabel "Ergolines"@fr, "Ergolines"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:narrower jvr:-M3D60RG5-1 .

jvr:-R0ZCQ8X6-J
  skos:prefLabel "agonistes (Qualificatif)"@fr, "agonists (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-D1BX72C0-B
  skos:prefLabel "Nootropiques"@fr, "Nootropic Agents"@en ;
  a mesh:Descriptor, skos:Concept .

jvr:-S0CS1X5R-5
  skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-M63HSDM7-1
  skos:prefLabel "antagonists & inhibitors (Qualifier)"@en, "antagonistes et inhibiteurs (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-HQRFT0C6-B
  skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-NB0XHT3S-N
  skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-W6SQV79N-S
  skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-CB30NGKB-3
  skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-G4R176S9-J
  skos:prefLabel "analogs & derivatives (Qualifier)"@en, "analogues et dérivés (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr: a skos:ConceptScheme .
jvr:-SBNWSM1T-R
  skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-K9FBN5C5-1
  skos:prefLabel "Vasodilator Agents"@en, "Vasodilatateurs"@fr ;
  a mesh:Descriptor, skos:Concept .

jvr:-D0F21513-5
  skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-R3QWLHRG-V
  skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NHL3D2X0-S
  skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-T9HQD7ST-J
  skos:prefLabel "ressources et distribution (Qualificatif)"@fr, "supply & distribution (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-NKM836P1-M
  skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-WK5F724J-1
  skos:prefLabel "pharmacokinetics (Qualifier)"@en, "pharmacocinétique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .